DSM-Firmenich began trading on 18 April and the exchange offer will be settled 20 April
The merger is said to be a 'transformational moment' for the companies
All transaction conditions for the May 2022-announced deal have been satisfied or waived, according to the companies.
As a result, the exchange offer will be settled on 20 April and the Firmenich contribution will occur on 8 May 2023.
DSM-Firmenich Ordinary Shares began trading under the symbol ‘DSFIR’ yesterday on Euronext Amsterdam.
Dutch-Swiss DSM and Firmenich began the exchange process in November 2022, with the merger described as a “transformational moment for the history of both businesses” by outgoing Firmenich CEO Gilbert Ghostine.
DSM-Firmenich comprises four businesses: Perfumery & Beauty; Health, Nutrition & Care, which covers the dietary supplements industry; Food & Beverage/Taste & Beyond; and Animal Nutrition & Health.
It is co-headquartered in Kaiseraugst, Switzerland and Maastricht in the Netherlands.
